Brain Watch

Brain Watch is developing a new generation of biomarker-based MRI molecular probes designed to improve diagnosis of neurodegenerative diseases and cancer based on functional substrate metabolism.

BrainWatch’s novel probes will enable rapid, accurate, specific and objective diagnosis of these diseases at an early stage and monitoring disease progression at a later stage. By using BrainWatch’s agents, physicians will be able to effectively tailor drug regimes to patients and improve the accuracy of intervention. Pharmaceutical companies will be able to use BrainWatch's biomarkers as tools for cost-effective development of drugs and to validate a disease modifying effect.